Published in World J Gastroenterol on July 21, 2008
Stem cell-based therapies for liver diseases: state of the art and new perspectives. Stem Cells Int (2010) 0.88
Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84
Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment. J Tissue Eng (2014) 0.80
Intestinal stem cells and celiac disease. World J Stem Cells (2014) 0.78
Autologous Stem Cells Transplantation in Egyptian Patients with Liver Cirrhosis on Top of Hepatitis C Virus. Int J Stem Cells (2015) 0.78
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Pluripotency of mesenchymal stem cells derived from adult marrow. Nature (2002) 19.57
Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 15.06
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature (2006) 11.90
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med (2004) 11.29
Cancer stem cells. N Engl J Med (2006) 9.63
Bone marrow as a potential source of hepatic oval cells. Science (1999) 8.52
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development (1990) 8.37
Stem cells and their niches. Science (2006) 7.86
Stem cells: units of development, units of regeneration, and units in evolution. Cell (2000) 7.36
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med (2002) 6.33
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
Stem cell niche: structure and function. Annu Rev Cell Dev Biol (2005) 5.33
Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology (2006) 4.61
Stem cells in normal breast development and breast cancer. Cell Prolif (2003) 4.47
The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A (2005) 4.12
Cancer stem cells: lessons from leukemia. Trends Cell Biol (2005) 3.90
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer (2007) 3.65
Normal stem cells and cancer stem cells: the niche matters. Cancer Res (2006) 3.60
CD133: molecule of the moment. J Pathol (2008) 3.58
Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol (2004) 3.41
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun (2006) 3.35
NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat Med (2003) 3.26
Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol (2003) 3.02
Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells (2006) 2.77
Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc Natl Acad Sci U S A (2005) 2.77
Stem cell concepts. Differentiation (1979) 2.67
Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science (1992) 2.40
Cytokines in inflammatory bowel disease. World J Surg (1998) 2.30
Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells (2006) 2.30
Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther (2007) 2.19
Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology (2001) 2.12
Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia (2004) 2.08
In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes (2004) 2.01
Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology (2006) 1.98
A role for chemistry in stem cell biology. Nat Biotechnol (2004) 1.95
Regeneration of pancreatic beta cells from intra-islet precursor cells in an experimental model of diabetes. Endocrinology (2001) 1.78
Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun (2006) 1.74
Partial hepatectomy induces mobilization of a unique population of haematopoietic progenitor cells in human healthy liver donors. J Hepatol (2005) 1.54
Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells (2005) 1.53
Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia (2005) 1.51
Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med (2007) 1.48
The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol (2001) 1.43
Feasibility and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Hepatol (2006) 1.43
Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol (2007) 1.39
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol (2006) 1.35
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood (2006) 1.31
Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice. Hepatology (2008) 1.27
Identification of stem cells from human umbilical cord blood with embryonic and hematopoietic characteristics. Exp Cell Res (2006) 1.25
In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mech Dev (2005) 1.23
High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells. Diabetes (2004) 1.18
Differentiation of human liver-derived, insulin-producing cells toward the beta-cell phenotype. Diabetes (2005) 1.17
Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology (2007) 1.17
Interstitial cells of Cajal at the clinical and scientific interface. J Physiol (2006) 1.13
CD34- hematopoietic stem cells: current concepts and controversies. Stem Cells (2003) 1.07
Hepatic stem cells: in search of. Stem Cells (2006) 1.07
Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun (2004) 1.04
Asymmetric cell kinetics genes: the key to expansion of adult stem cells in culture. Stem Cells (2002) 1.04
Embryonic stem cell transplantation: potential applicability in cell replacement therapy and regenerative medicine. Front Biosci (2007) 1.00
Towards stem-cell therapy in the endocrine pancreas. Trends Mol Med (2007) 0.99
An introduction to stem cells. J Pathol (2002) 0.99
Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology (2004) 0.98
Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol (2006) 0.98
Stem cell therapy for human liver cirrhosis: a cautious analysis of the results. Stem Cells (2007) 0.96
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. Dig Liver Dis (2006) 0.96
Update on the management of refractory coeliac disease. J Gastrointestin Liver Dis (2007) 0.95
Stem cell mobilization and collection in patients with liver cirrhosis. Aliment Pharmacol Ther (2008) 0.95
Cancer stem cells. Pediatr Res (2006) 0.93
Can old cells learn new tricks? Science (2000) 0.90
Bone marrow stem cell-mediated regeneration in IBD: where do we go from here? Gastroenterology (2007) 0.89
Stem cells and regenerative medicine for diabetes mellitus. Pancreas (2004) 0.89
Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun (2004) 0.87
Stem cell-based therapy in gastroenterology and hepatology. Minim Invasive Ther Allied Technol (2008) 0.87
Human cord blood--derived cells generate insulin-producing cells in vivo. Stem Cells (2005) 0.86
Microarray RNA/DNA in different stem cell lines. Curr Pharm Biotechnol (2007) 0.84
Efficiency of bone marrow-derived cells in regeneration of the stomach after induction of ethanol-induced ulcers in rats. J Gastroenterol (2005) 0.84
The treatment of cancer in Greek antiquity. Eur J Cancer (2004) 0.82
Stem cells: new tools in gastroenterology and hepatology. Dig Liver Dis (2003) 0.81
Mobilizing stem cells to repair liver after surgery: dream or reality? J Hepatol (2005) 0.79
Cell-based therapy for liver diseases. Eur Rev Med Pharmacol Sci (2003) 0.79
Stem cells, cancer, liver, and liver cancer stem cells: finding a way out of the labyrinth... Curr Cancer Drug Targets (2007) 0.78
When biology bursts into the clinic: stem cells and their potential. Eur Rev Med Pharmacol Sci (2002) 0.77
Harnessing the gut to treat diabetes. Pediatr Diabetes (2004) 0.77
Adult stem cells and their ability to differentiate. Med Sci Monit (2006) 0.77